During the past decade, Baylor Breast Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor Breast Center" #1 sponsor was "Baylor Breast Care Center" with 12 trials, followed by "Mothaffar Rimawi" with 3 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "Vanderbilt-Ingram Cancer Center" with 2 trials sponsored and "Dana-Farber Cancer Institute" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Breast Center" #1 collaborator was "Genentech, Inc." with 4 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "Translational Breast Cancer Research Consortium" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Baylor College of Medicine" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Breast Center" are "Breast Cancer" (15 trials), "BREAST CANCER" (2 trials), "Stage IV Breast Cancer" (2 trials), "Alopecia" (1 trials) and "Estrogen Receptor Negative" (1 trials). Many other conditions were trialed in "Baylor Breast Center" in a lesser frequency.

Most popular intervention types in "Baylor Breast Center" are "Drug" (21 trials), "Other" (4 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Taxotere" (3 trials), "Trastuzumab" (3 trials), "Lapatinib" (2 trials), "Letrozole" (2 trials) and "Tamoxifen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Breast Center" are 18 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Breast Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Baylor Breast Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Breast Center, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".